oseltamivir has been researched along with Cholera Infantum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armano, R; Blumental, S; Cornet, MC; De Schutter, I; Ferreiro, C; Fonteyne, C; Hermans, D; Huisman, E; Kabamba-Mukadi, B; Lepage, P; Levy, J; Mahadeb, B; Malfroot, A; Moulin, D; Nassogne, MC; Reynders, M; Van Berlaer, G; Vergison, A; Wybo, I | 1 |
| Benjamin, JH; Gardner, C; Green, K; Lee, W; Loeb, M; McArthur, M; McGeer, AJ; Simor, AE | 1 |
2 other study(ies) available for oseltamivir and Cholera Infantum
| Article | Year |
|---|---|
Pandemic A/H1N1v influenza 2009 in hospitalized children: a multicenter Belgian survey.
Topics: Adolescent; Age Distribution; Anti-Bacterial Agents; Antiviral Agents; Belgium; Child; Child, Hospitalized; Child, Preschool; Critical Care; Female; Gastrointestinal Diseases; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Nervous System Diseases; Oseltamivir; Pandemics; Respiratory Tract Diseases; Survival Analysis | 2011 |
Adverse effects of amantadine and oseltamivir used during respiratory outbreaks in a center for developmentally disabled adults.
Topics: Acetamides; Adult; Aged; Amantadine; Antiviral Agents; Child; Comorbidity; Developmental Disabilities; Disease Outbreaks; Female; Gastrointestinal Diseases; Humans; Incidence; Infection Control; Long-Term Care; Male; Middle Aged; Nervous System Diseases; Ontario; Oseltamivir; Respiratory Tract Infections; Severity of Illness Index | 2004 |